Franklin Street Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.9M Sell
83,653
-9,688
-10% -$4.65M 2.34% 11
2026
Q1
$45.9M Sell
93,341
-9,767
-9% -$5.3M 2.82% 9
2025
Q4
$59.7M Sell
103,108
-986
-0.9% -$558K 3.41% 7
2025
Q3
$50.5M Buy
104,094
+87,872
+542% +$40.9M 2.91% 8
2025
Q2
$6.58M Sell
16,222
-16,481
-50% -$6.89M 0.41% 48
2025
Q1
$16.3M Sell
32,703
-883
-3% -$478K 1.15% 32
2024
Q4
$17.5M Sell
33,586
-8,457
-20% -$4.65M 1.16% 31
2024
Q3
$26M Buy
42,043
+3,599
+9% +$2.13M 1.75% 16
2024
Q2
$21.3M Buy
38,444
+6,220
+19% +$3.56M 1.52% 21
2024
Q1
$18.7M Sell
32,224
-430
-1% -$241K 1.39% 24
2023
Q4
$17.3M Sell
32,654
-2,036
-6% -$985K 1.42% 27
2023
Q3
$17.6M Sell
34,690
-804
-2% -$428K 1.56% 23
2023
Q2
$18.5M Sell
35,494
-7,954
-18% -$4.29M 1.57% 23
2023
Q1
$25M Sell
43,448
-3,890
-8% -$2.19M 2.28% 13
2022
Q4
$26.1M Sell
47,338
-3,671
-7% -$1.95M 2.48% 9
2022
Q3
$25.9M Buy
51,009
+2,217
+5% +$1.24M 2.62% 10
2022
Q2
$26.5M Buy
48,792
+8,197
+20% +$4.51M 2.51% 9
2022
Q1
$24M Buy
40,595
+10,521
+35% +$6.04M 1.94% 15
2021
Q4
$20.1M Sell
30,074
-1,565
-5% -$977K 1.52% 24
2021
Q3
$18.1M Sell
31,639
-1,187
-4% -$651K 1.53% 21
2021
Q2
$16.6M Sell
32,826
-396
-1% -$187K 1.4% 24
2021
Q1
$15.2M Buy
33,222
+1,528
+5% +$729K 1.41% 23
2020
Q4
$14.8M Sell
31,694
-736
-2% -$345K 1.43% 25
2020
Q3
$14.3M Buy
32,430
+8,557
+36% +$3.54M 1.54% 23
2020
Q2
$8.65M Buy
23,873
+509
+2% +$171K 1.03% 37
2020
Q1
$6.63M Sell
23,364
-199
-0.8% -$62.8K 0.97% 43
2019
Q4
$7.66M Buy
23,563
+205
+0.9% +$62.2K 0.91% 52
2019
Q3
$6.8M Sell
23,358
-191
-0.8% -$54.7K 0.86% 49
2019
Q2
$6.92M Buy
23,549
+448
+2% +$123K 0.89% 49
2019
Q1
$6.32M Buy
23,101
+390
+2% +$97.1K 0.88% 48
2018
Q4
$5.08M Buy
22,711
+82
+0.4% +$19.2K 0.8% 52
2018
Q3
$5.52M Sell
22,629
-345
-2% -$79.4K 0.75% 52
2018
Q2
$4.76M Buy
22,974
+395
+2% +$83.8K 0.69% 54
2018
Q1
$4.66M Buy
22,579
+990
+5% +$208K 0.7% 57
2017
Q4
$4.1M Buy
21,589
+220
+1% +$42.1K 0.61% 58
2017
Q3
$4.04M Buy
21,369
+1,060
+5% +$192K 0.66% 59
2017
Q2
$3.54M Buy
20,309
+315
+2% +$52.9K 0.61% 59
2017
Q1
$3.07M Buy
19,994
+565
+3% +$86.4K 0.54% 62
2016
Q4
$2.74M Sell
19,429
-532
-3% -$78.4K 0.48% 63
2016
Q3
$3.17M Sell
19,961
-5,035
-20% -$776K 0.58% 64
2016
Q2
$3.69M Buy
24,996
+145
+0.6% +$21.4K 0.7% 56
2016
Q1
$3.52M Sell
24,851
-18,485
-43% -$2.48M 0.7% 52
2015
Q4
$6.15M Sell
43,336
-1,480
-3% -$197K 1.21% 21
2015
Q3
$5.48M Buy
44,816
+7,310
+19% +$952K 1.09% 28
2015
Q2
$4.87M Sell
37,506
-295
-0.8% -$38.5K 0.87% 38
2015
Q1
$5.08M Sell
37,801
-1,225
-3% -$158K 0.93% 35
2014
Q4
$4.89M Buy
39,026
+180
+0.5% +$21.9K 0.93% 40
2014
Q3
$4.73M Buy
38,846
+3,550
+10% +$432K 0.9% 38
2014
Q2
$4.17M Buy
35,296
+2,185
+7% +$257K 0.8% 41
2014
Q1
$3.98M Buy
33,111
+815
+3% +$96.9K 0.8% 43
2013
Q4
$3.6M Buy
32,296
+765
+2% +$76.1K 0.73% 44
2013
Q3
$2.91M Buy
31,531
+23,907
+314% +$2.16M 0.65% 46
2013
Q2
$645K Buy
+7,624
New +$635K 0.16% 152

Other funds holding TMO

Franklin Street Advisors's TMO Position: Q2 2026 in Review

Franklin Street Advisors reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $4.65M and leaving 83,653 shares worth $41.9M. The position accounts for 2.34% of the portfolio, ranked #11.

Franklin Street Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $59.7M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Franklin Street Advisors held 83,653 shares of Thermo Fisher Scientific worth $41.9M as of Q2 2026.
  • Franklin Street Advisors sold 9,688 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.65M.
  • Thermo Fisher Scientific made up 2.34% of Franklin Street Advisors's portfolio in Q2 2026, its #11 holding.
  • Franklin Street Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Franklin Street Advisors's Thermo Fisher Scientific position peaked at $59.7M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.